Mechanism of Anti-α-Synuclein Immunotherapy

Immunization therapy targeting α-synuclein has emerged as a promising approach for Parkinson’s disease and perhaps for other synucleinopathies. Several antibodies have shown therapeutic effects in mouse models of synucleinopathies and have alleviated the pathological and behavioral phenotypes of the...

Full description

Bibliographic Details
Main Authors: Jun Sung Lee, Seung-Jae Lee
Format: Article
Language:English
Published: Korean Movement Disorder Society 2016-01-01
Series:Journal of Movement Disorders
Subjects:
Online Access:http://e-jmd.org/upload/jmd-15059.pdf
_version_ 1797716084977041408
author Jun Sung Lee
Seung-Jae Lee
author_facet Jun Sung Lee
Seung-Jae Lee
author_sort Jun Sung Lee
collection DOAJ
description Immunization therapy targeting α-synuclein has emerged as a promising approach for Parkinson’s disease and perhaps for other synucleinopathies. Several antibodies have shown therapeutic effects in mouse models of synucleinopathies and have alleviated the pathological and behavioral phenotypes of these mice. The mechanisms through which the immunization therapy works were initially puzzling, especially given that α-synuclein is a typical cytosolic protein. Recent studies, however, suggested that extracellular α-synuclein is an important pathogenic entity, and hence, a target for immunotherapy. Here, we review the literature describing immunization therapy for synucleinopathies in mouse models and provide current thoughts on the potential mechanisms underlying the therapeutic effects of α-synuclein immunotherapy.
first_indexed 2024-03-12T08:16:18Z
format Article
id doaj.art-ebc331f95a8b4d7086417ea08efc86d0
institution Directory Open Access Journal
issn 2005-940X
2093-4939
language English
last_indexed 2024-03-12T08:16:18Z
publishDate 2016-01-01
publisher Korean Movement Disorder Society
record_format Article
series Journal of Movement Disorders
spelling doaj.art-ebc331f95a8b4d7086417ea08efc86d02023-09-02T18:53:33ZengKorean Movement Disorder SocietyJournal of Movement Disorders2005-940X2093-49392016-01-0191141910.14802/jmd.15059151Mechanism of Anti-α-Synuclein ImmunotherapyJun Sung LeeSeung-Jae LeeImmunization therapy targeting α-synuclein has emerged as a promising approach for Parkinson’s disease and perhaps for other synucleinopathies. Several antibodies have shown therapeutic effects in mouse models of synucleinopathies and have alleviated the pathological and behavioral phenotypes of these mice. The mechanisms through which the immunization therapy works were initially puzzling, especially given that α-synuclein is a typical cytosolic protein. Recent studies, however, suggested that extracellular α-synuclein is an important pathogenic entity, and hence, a target for immunotherapy. Here, we review the literature describing immunization therapy for synucleinopathies in mouse models and provide current thoughts on the potential mechanisms underlying the therapeutic effects of α-synuclein immunotherapy.http://e-jmd.org/upload/jmd-15059.pdfSynucleinopathyα-synucleinAggregate transmissionMicroglia activationImmunotherapy
spellingShingle Jun Sung Lee
Seung-Jae Lee
Mechanism of Anti-α-Synuclein Immunotherapy
Journal of Movement Disorders
Synucleinopathy
α-synuclein
Aggregate transmission
Microglia activation
Immunotherapy
title Mechanism of Anti-α-Synuclein Immunotherapy
title_full Mechanism of Anti-α-Synuclein Immunotherapy
title_fullStr Mechanism of Anti-α-Synuclein Immunotherapy
title_full_unstemmed Mechanism of Anti-α-Synuclein Immunotherapy
title_short Mechanism of Anti-α-Synuclein Immunotherapy
title_sort mechanism of anti α synuclein immunotherapy
topic Synucleinopathy
α-synuclein
Aggregate transmission
Microglia activation
Immunotherapy
url http://e-jmd.org/upload/jmd-15059.pdf
work_keys_str_mv AT junsunglee mechanismofantiasynucleinimmunotherapy
AT seungjaelee mechanismofantiasynucleinimmunotherapy